Sana Biotechnology (SANA) Operating Expenses (2020 - 2026)

Sana Biotechnology's Operating Expenses history runs 7 years deep, the most recent figure standing at $48.6 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 3.98% year-over-year to $48.6 million; the TTM figure through Mar 2026 stood at $338.2 million (up 181.12% YoY), while the FY2025 annual figure was $250.3 million, up 1575.05% from the prior year.
• Operating Expenses came in at $48.6 million for Q1 2026 at Sana Biotechnology, down from $243.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $243.8 million in Q4 2025 to a low of -$162.2 million in Q4 2022.
• A 5-year average of $46.1 million and a median of $48.6 million in 2026 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slumped 245.76% in 2022 and soared 9258.46% in 2025, its largest moves.
• Sana Biotechnology's Operating Expenses stood at -$162.2 million in 2022, then surged by 155.87% to $90.6 million in 2023, then tumbled by 97.13% to $2.6 million in 2024, then jumped by 9258.46% to $243.8 million in 2025, then slumped by 80.06% to $48.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $48.6 million, $243.8 million, and $43.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison